Revelation Biosciences REVB
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 1.2 | -2.71 | -3,092 | -3 | ||
| 2025Q4 | 3.2 | 102.43 | 15.09 | -2,572 | -3 | |
| 2025Q3 | 5.68 | 101.89 | 15.36 | -1,943 | -2 | |
| 2025Q2 | 9 | 100.7 | -29.08 | -2,461 | -2 | |
| 2025Q1 | 31.56 | 102.15 | -25.32 | -2,095 | -2 | |
| 2024Q4 | 88.51 | 101.62 | 364.04 | -1,754 | -2 | |
| 2024Q3 | 163.55 | 80.15 | 143.88 | -1,797 | -2 | |
| 2024Q2 | 366.72 | 30.06 | -1087.64 | -2,522 | -8 | |
| 2024Q1 | 526.08 | 70.94 | -472.44 | -1,902 | -3 | |
| 2023Q4 | 2884.03 | 105.58 | 3.6 | -1902.26 | -2,326 | -2 |
| 2023Q3 | 3970.94 | 105.71 | 1.86 | -2785.95 | -2,778 | -3 |
| 2023Q2 | 5414.4 | 133.49 | 2.92 | -2530.59 | -1,933 | -1 |
| 2023Q1 | 7488 | -26.3 | 7117.51 | -1,620 | 6 | |
| 2022Q4 | 38324.16 | 100.91 | 84319.34 | -1,218 | -1 | |
| 2022Q3 | 52617.6 | 102.48 | 576.06 | -1,199 | -1 | |
| 2022Q2 | 223776 | 101.42 | -21948.01 | -1,860 | -2 | |
| 2022Q1 | 229824 | 99.55 | -91594.08 | -6,586 | -7 | |
| 2021Q4 | 82.91 | 527424.62 | 5,005 | 6 | ||
| 2021Q3 | 69.38 | -447623.62 | 2,894 | 4 | ||
| 2021Q2 | 52.72 | -239942.39 | 1,297 | 2 |